Related Experiment Videos
[Fibrinolysis, interleukins and coronary atherosclerosis]
Insights
This study found reduced plasminogen activator activity in patients with angina and arrhythmias, but not hypertension. Interleukin 1 and 2 levels decreased across all atherosclerosis patients studied.
Area of Science:
- Cardiology
- Immunology
- Hematology
Background:
- Atherosclerosis involves complex cardiovascular and inflammatory processes.
- The fibrinolytic system and interleukins play roles in cardiovascular health.
- Understanding these markers can aid in diagnosing and managing atherosclerosis complications.
Purpose of the Study:
- To investigate the fibrinolytic system and interleukin 1 and 2 activity in patients with cardiac manifestations of atherosclerosis.
- To correlate these activities with specific conditions like angina, arrhythmia, and hypertension.
Main Methods:
- Studied 75 patients with various cardial manifestations of atherosclerosis.
- Assessed the activity of plasminogen activators.
- Measured the activity of interleukin 1 and interleukin 2.
Main Results:
- Decreased plasminogen activator activity was observed in patients with angina of effort, angina decubitus, and cardiac arrhythmias.
- Plasminogen activator activity remained within normal limits in patients with atherosclerotic hypertension.
- Reduced activity of interleukin 1 and interleukin 2 was noted in all examined patients.
Conclusions:
- Fibrinolytic system dysfunction may be linked to specific atherosclerotic cardiac conditions.
- Interleukin 1 and 2 activity reduction is a common finding across studied atherosclerosis patients.
- These findings suggest potential biomarkers for atherosclerosis-related cardiac issues.
Abstract:
The study of the fibrinolytic system and the activity of interleukin 1 and 2 in 75 patients with various cardial manifestations of atherosclerosis (angina of effort, angina decubitus, arrhythmia, symptomatic hypertension) revealed a decrease in the activity of plasminogen--a blood activator--in patients with angina of effort, angina decubitus and cardiac arrhythmias. In those with atherosclerotic hypertension the activatory activity was in the normal limits. A decrease in the activity of interleukin 1 and 2 was noted in all those examined.